ASP
  • COVID
    • INPATIENT >
      • CONSIDERATIONS & LABS
      • PAXLOVID
      • REMDESIVIR
      • OLUMIANT
      • ACTEMRA
      • STEROIDS
      • VTE
    • OUTPATIENT
  • Education
    • Bugs & Tips
    • Agents & Spectra
  • Guidelines
    • By Infection Type
    • Surgical Prophylaxis >
      • By Procedure
      • Dosing Guide
  • Formulary
  • Antibiogram
    • 2023 Inpatient
    • 2023 Outpatient
    • 2022 Inpatient
    • 2022 Outpatient
    • 2021 Inpatient
    • 2021 Outpatient
    • 2020 Inpatient
    • 2019 Inpatient
    • 2019 Outpatient
  • About
    • ASP Program
    • Stats & Data >
      • Recommendations
      • Pharmacy Data
      • MDR ORGANISMS
      • DDD/DOT
    • Contact

Neisseria MENINGITIS
​(aka "meningococcus")

LAB WORK​
  • G(-) diplococcus, polysaccharide capsule; 13 serogroups (based on capsule)

TREATMENT​ OPTIONS
  • ​Almost all strains are susceptible to penicillins - Drug of choice is Rocephin or high dose penicillin G
  • Most strains resistant to sulfonamides

​CLINICAL NOTES​
  • Typically affects young kids, college freshmen, and military recruits
  • Second most common cause of community-acquired meningitis; can also cause pneumonia, myocarditis, and bacteremia (persistent meningococcal bacteremia, or chronic meningococcemia, associated with low grade fever, rash, and arthritis)
  • Petechial rash - characteristic of meningococcal disease
    • Lesions 1-2 mm in diameter, typically on trunk or lower parts of the body
    • Associated with thrombocytopenia which may be an indicator of disseminated intravascular coagulopathy
  • Immunization 
    • Two types of active quadrivalent vaccines against serotypes A, C, Y, and W-135; does not prevent serotype B which is responsible for invasive disease in infants
      • Menactra: conjugate vaccine, preferred over polysaccharide vaccine in patients 55 years old or younger
      • Menomune: polysaccharide vaccine
  • COVID
    • INPATIENT >
      • CONSIDERATIONS & LABS
      • PAXLOVID
      • REMDESIVIR
      • OLUMIANT
      • ACTEMRA
      • STEROIDS
      • VTE
    • OUTPATIENT
  • Education
    • Bugs & Tips
    • Agents & Spectra
  • Guidelines
    • By Infection Type
    • Surgical Prophylaxis >
      • By Procedure
      • Dosing Guide
  • Formulary
  • Antibiogram
    • 2023 Inpatient
    • 2023 Outpatient
    • 2022 Inpatient
    • 2022 Outpatient
    • 2021 Inpatient
    • 2021 Outpatient
    • 2020 Inpatient
    • 2019 Inpatient
    • 2019 Outpatient
  • About
    • ASP Program
    • Stats & Data >
      • Recommendations
      • Pharmacy Data
      • MDR ORGANISMS
      • DDD/DOT
    • Contact